COVID-19-associated vasculitis and vasculopathy
RC Becker - Journal of thrombosis and thrombolysis, 2020 - Springer
The COVID-19 pandemic now totaling 13,000,000 cases and over 571,000 deaths has
continued to teach the medical, scientific and lay communities about viral infectious disease …
continued to teach the medical, scientific and lay communities about viral infectious disease …
Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review
I Cheruiyot, V Kipkorir, B Ngure, M Misiani… - Annals of vascular …, 2021 - Elsevier
Background Emerging evidence suggests that severe form of coronavirus disease 2019
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …
Thrombotic complications of COVID-19
Introduction The novel coronavirus disease of 2019 (COVID-19) is associated with
significant morbidity and mortality. The impact of thrombotic complications has been …
significant morbidity and mortality. The impact of thrombotic complications has been …
Thromboembolic disease in COVID-19 patients: a brief narrative review
S Mondal, AL Quintili, K Karamchandani… - Journal of intensive care, 2020 - Springer
Abstract Corona virus 2 (SARS-CoV2/Severe Acute Respiratory Syndrome Corona Virus 2)
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …
SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group
Background and Purpose: Stroke is reported as a consequence of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection in several reports. However, data are …
syndrome coronavirus-2 (SARS-CoV-2) infection in several reports. However, data are …
Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus
UK Katneni, A Alexaki, RC Hunt… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease of 2019 (COVID-19) is the clinical manifestation of the respiratory
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool
Abstract Background Coronavirus disease 2019 (COVID-19) pandemic has drastically
affected global health. Despite several studies, there is yet a dearth of data regarding the …
affected global health. Despite several studies, there is yet a dearth of data regarding the …
Mortality of COVID-19 patients with vascular thrombotic complications
JA Gonzalez-Fajardo, M Ansuategui, C Romero… - … Clínica (English Edition), 2021 - Elsevier
Purpose To analyze the survival of patients hospitalized with COVID-19 and who presented
some vascular thrombotic complication. Material and Methods All consecutive patients with …
some vascular thrombotic complication. Material and Methods All consecutive patients with …
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: a systematic review
S Tomerak, S Khan, M Almasri… - Scandinavian …, 2021 - Wiley Online Library
COVID‐19 is a global pandemic with a daily increasing number of affected individuals.
Thrombosis is a severe complication of COVID‐19 that leads to a worse clinical course with …
Thrombosis is a severe complication of COVID‐19 that leads to a worse clinical course with …
Acute limb ischemia in hospitalized COVID-19 patients
AC Topcu, G Ozturk-Altunyurt, D Akman, A Batirel… - Annals of vascular …, 2021 - Elsevier
Background COVID-19 is a multisystemic disorder. Hematologic and cardiovascular
involvement of COVID-19 causes thromboembolic events across multiple organs which …
involvement of COVID-19 causes thromboembolic events across multiple organs which …